We are live on ! Find out more
AC

Ascend Capital Portfolio holdings

AUM $1.99B
1-Year Est. Return 10.36%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+10.36%
3 Year Est. Return
+56.79%
5 Year Est. Return
+86.43%
10 Year Est. Return
AUM
$3.28B
AUM Growth
+$597M
Cap. Flow
+$166M
Cap. Flow %
5.04%
Top 10 Hldgs %
22.55%
Holding
268
New
71
Increased
59
Reduced
39
Closed
90

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.75%
2 Healthcare 13.67%
3 Technology 10.55%
4 Financials 10.48%
5 Materials 10.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WCRX
251
DELISTED
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
-509,104
Closed -$11.7M
CAM
252
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
-200,000
Closed -$11.7M
HOT
253
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
-564,000
Closed -$37.5M
MTGE
254
DELISTED
MTGE Investment Corp. Common Stock
MTGE
-225,572
Closed -$4.46M
OREX
255
DELISTED
Orexigen Therapeutics, Inc.
OREX
-9,319
Closed -$572K
KKD
256
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
-498,685
Closed -$9.64M
LNCO
257
PUT
DELISTED
LINNCO LLC COM SHS REPSTG LTD LIABILITY
LNCO
-20,000
Closed -$584K
TWC
258
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
-20,000
Closed -$2.23M

Similar funds

Ascend Capital's Q4 2013 Portfolio in Review

As of Q4 2013, Ascend Capital held 268 positions worth $3.28B, up 22% from $2.69B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ascend Capital deployed $166M of net new capital in Q4 2013, opening 71 new positions and adding to 59 existing holdings. Its largest new stake was Teva Pharmaceuticals: 1,975,045 shares worth $79.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Liberty Interactive Corporation Series A Liberty Ventures, an estimated $57.9M trimmed.

  • Ascend Capital's largest Q4 2013 buy was Teva Pharmaceuticals: 1,975,045 shares worth $79.2M.
  • Ascend Capital added most to Host Hotels & Resorts in Q4 2013, an estimated $67.9M increase.
  • Ascend Capital's biggest Q4 2013 reduction was Liberty Interactive Corporation Series A Liberty Ventures, cutting an estimated $57.9M.
  • Ascend Capital fully exited Perrigo in Q4 2013, selling an estimated $58.5M.
  • Ascend Capital's ten largest holdings make up 23% of its $3.28B portfolio in Q4 2013.
  • Ascend Capital opened 71 new positions and closed 90 in Q4 2013.
  • Ascend Capital's portfolio value rose 22% quarter-over-quarter to $3.28B.

Based on Ascend Capital's 13F filing for Q4 2013, filed 14 Feb 2014.